Gossamer Bio, Inc. (GOSS)
0.3389
-0.01
(-3.23%)
USD |
NASDAQ |
May 07, 15:43
Gossamer Bio SG&A Expense (TTM) : 37.63M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 237.95M |
| Artelo Biosciences, Inc. | 5.981M |
| Arvinas, Inc. | 95.90M |
| Quince Therapeutics, Inc. | 15.05M |
| Vir Biotechnology, Inc. | 92.07M |